Katherine Stueland
Chief Executive Officer at GeneDx Holdings · 8 reported transactions in 1 company · latest trade Sep 16, 2026
Their trades
Sold | Sep 16, 2026 | Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days. | ||
Sold | Sep 16, 2026 | Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days. | ||
Sold | Sep 16, 2026 | Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days. | ||
Sold | Sep 16, 2026 | Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days. | ||
Sold | Sep 16, 2026 | Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days. | ||
Sold | Sep 9, 2026 | Sep 9, 2026 close $86.48 → Oct 29, 2026 close $71.02. S&P 500 +0.9% over the same days. |
SoldGeneDx Holdings
$300.8K
Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days.
SoldGeneDx Holdings
$406.9K
Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days.
SoldGeneDx Holdings
$147.8K
Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days.
SoldGeneDx Holdings
$14.1K
Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days.
SoldGeneDx Holdings
$155.3K
Sep 16, 2026 close $97.42 → Oct 29, 2026 close $71.02. S&P 500 +2.0% over the same days.
SoldGeneDx Holdings
$310.9K
Sep 9, 2026 close $86.48 → Oct 29, 2026 close $71.02. S&P 500 +0.9% over the same days.